V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001797 | 230006420 | 1.65 | 58 | Palliative (P) | 2019-01-28 | 2019-04-30 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100611585 |
| 230001798 | 230006421 | 1.61 | 65.85 | Adjuvant (A) | 2017-08-12 | 2019-07-27 | Niraparib | 02 | N | NIRAPARIB | 101110498 |
| 230001799 | 230006422 | null | null | null | null | 2020-03-04 | null | null | null | OLAPARIB | 100885524 |
| 230001803 | 230006424 | null | null | null | 2018-11-12 | 2018-11-12 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101136294 |
| 230001808 | 230006426 | 1.6 | 96.2 | Palliative (P) | null | 2020-12-04 | null | 02 | N | TRASTUZUMAB | 100134614 |
| 230001809 | 230006427 | 1.82 | 71.3 | null | 2020-05-21 | 2020-05-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100132664 |
| 230001812 | 230006430 | 1.52 | 127 | Neo-adjuvant (N) | 2019-11-13 | 2019-11-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101686049 |
| 230001814 | 230006432 | 1.65 | 63.2 | Curative (C) | 2021-02-06 | 2021-09-10 | null | null | N | CARBOPLATIN + GEMCITABINE | 100999846 |
| 230001817 | 230006434 | 1.62 | 58.8 | null | 2018-04-22 | 2019-05-03 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100834006 |
| 230001818 | 230006435 | 1.63 | 80 | null | null | 2019-10-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101084133 |
| 230001822 | 230006439 | null | null | Curative (C) | 2019-06-04 | 2019-06-09 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101218559 |
| 230001823 | 230006440 | null | null | Palliative (P) | null | 2019-09-25 | Cisplatin | 01 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100891145 |
| 230001829 | 230006445 | 1.65 | 71.4 | null | null | 2020-03-19 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100408458 |
| 230001835 | 230006447 | 1.66 | 68.4 | Neo-adjuvant (N) | 2019-05-29 | 2019-07-01 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101058651 |
| 230001836 | 230006448 | 1.5 | 57.3 | null | null | 2018-11-21 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101573628 |
| 230001838 | 230006449 | 1.66 | 49.5 | null | 2020-04-28 | 2020-04-30 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100117641 |
| 230001839 | 230006450 | 1.86 | 75 | null | null | 2020-12-14 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101038703 |
| 230001840 | 230006451 | 1.56 | 70.1 | null | null | 2020-12-09 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100630875 |
| 230001841 | 230006452 | 1.51 | 55.7 | null | 2017-06-27 | 2017-07-03 | null | null | null | TRASTUZUMAB EMTANSINE | 101359449 |
| 230001842 | 230006453 | 1.7 | 60.7 | null | 2021-05-11 | 2021-05-12 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100122203 |
| 230001846 | 230006455 | 1.65 | 81.85 | null | 2019-02-13 | 2019-03-27 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100249299 |
| 230001847 | 230006456 | 1.62 | 61.6 | Palliative (P) | null | 2020-08-16 | Bevacizumab | 02 | N | BEVACIZUMAB | 101281306 |
| 230001849 | 230006458 | 1.71 | 86.3 | null | null | 2020-04-22 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100280148 |
| 230001850 | 230006459 | null | null | null | 2018-04-03 | 2018-04-18 | null | null | null | LIPOSOMAL DOXORUBICIN | 100891161 |
| 230001854 | 230006461 | 1.63 | 93 | null | null | 2020-04-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101816803 |
| 230001860 | 230006465 | 1.61 | 110.5 | null | null | 2019-12-03 | null | null | null | LIPOSOMAL DOXORUBICIN | 100210848 |
| 230001861 | 230006466 | null | null | null | 2021-12-31 | 2022-01-08 | null | 02 | null | TRIAL UNSPECIFIED | 100123044 |
| 230001865 | 230006468 | 1.5 | 0 | null | 2017-03-28 | 2017-11-20 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101083578 |
| 230001866 | 230006469 | 1.73 | null | Palliative (P) | 2019-12-21 | 2019-12-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100122229 |
| 230001869 | 230006471 | 1.49 | 96.6 | Palliative (P) | null | 2019-04-29 | Olaparib | 02 | N | OLAPARIB | 100535021 |
| 230001870 | 230006472 | 1.6 | 59.8 | null | 2021-05-30 | 2021-12-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101857326 |
| 230001873 | 230006473 | null | null | null | 2020-09-10 | 2020-09-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | CISPLATIN + ETOPOSIDE | 101552669 |
| 230001874 | 230006474 | 1.57 | 91.55 | Palliative (P) | null | 2021-12-12 | null | N | N | CARBOPLATIN | 101123322 |
| 230001878 | 230006477 | null | null | Neo-adjuvant (N) | 2016-09-10 | 2016-10-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100969254 |
| 230001879 | 230006478 | null | null | Palliative (P) | null | 2022-02-10 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101577356 |
| 230001881 | 230006480 | null | null | null | 2015-08-13 | 2016-02-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100660284 |
| 230001882 | 230006481 | 1.63 | 74.5 | null | null | 2018-02-21 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101329981 |
| 230001886 | 230006483 | 1.52 | 63.2 | 03 | null | 2016-12-22 | Bevacizumab | 02 | N | BEVACIZUMAB | 100798503 |
| 230001890 | 230006486 | 1.58 | 66 | null | null | 2019-05-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101429851 |
| 230001891 | 230006487 | 1.49 | 84 | null | null | 2019-08-23 | null | 02 | null | TRIAL UNSPECIFIED | 100321720 |
| 230001892 | 230006488 | 1.58 | 127 | Palliative (P) | null | 2019-01-27 | null | null | N | TRIAL UNSPECIFIED | 100977905 |
| 230001894 | 230006489 | null | null | null | 2019-02-07 | 2019-03-06 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101088439 |
| 230001895 | 230006490 | 1.66 | 60.9 | null | null | 2020-01-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100799567 |
| 230001898 | 230006492 | 1.65 | 49.6 | null | null | 2016-03-30 | Olaparib | 02 | null | OLAPARIB | 101715764 |
| 230001900 | 230006493 | 1.5 | 72 | null | 2019-06-22 | 2019-07-05 | null | null | null | OLAPARIB | 100600903 |
| 230001901 | 230006494 | null | null | null | 2020-11-27 | 2020-12-08 | null | 01 | null | PACLITAXEL | 101360949 |
| 230001903 | 230006495 | 1.57 | 61 | Palliative (P) | 2019-04-20 | 2019-09-22 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100289576 |
| 230001907 | 230006497 | null | null | null | null | 2019-07-21 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101050409 |
| 230001909 | 230006498 | 1.57 | 74.5 | null | 2020-03-09 | 2020-11-14 | null | null | null | NIRAPARIB | 100692521 |
| 230001911 | 230006499 | null | null | null | null | 2017-02-11 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100037088 |